Dyadic International Inc (DYAI)
1.49
-0.01
(-0.67%)
USD |
NASDAQ |
Apr 25, 16:00
1.49
0.00 (0.00%)
After-Hours: 20:00
Dyadic International Price to Book Value: 7.344 for April 25, 2024
Price to Book Value Chart
Historical Price to Book Value Data
Date | Value |
---|---|
April 25, 2024 | 7.344 |
April 24, 2024 | 7.393 |
April 23, 2024 | 7.344 |
April 22, 2024 | 7.541 |
April 19, 2024 | 7.837 |
April 18, 2024 | 7.837 |
April 17, 2024 | 8.280 |
April 16, 2024 | 8.872 |
April 15, 2024 | 8.231 |
April 12, 2024 | 8.675 |
April 11, 2024 | 9.044 |
April 10, 2024 | 8.921 |
April 09, 2024 | 9.414 |
April 08, 2024 | 9.217 |
April 05, 2024 | 8.921 |
April 04, 2024 | 9.168 |
April 03, 2024 | 8.872 |
April 02, 2024 | 8.625 |
April 01, 2024 | 8.231 |
March 28, 2024 | 8.231 |
March 27, 2024 | 8.034 |
March 26, 2024 | 7.744 |
March 25, 2024 | 8.038 |
March 22, 2024 | 7.842 |
March 21, 2024 | 7.989 |
Date | Value |
---|---|
March 20, 2024 | 8.185 |
March 19, 2024 | 7.793 |
March 18, 2024 | 7.744 |
March 15, 2024 | 7.352 |
March 14, 2024 | 7.450 |
March 13, 2024 | 7.842 |
March 12, 2024 | 7.254 |
March 11, 2024 | 7.156 |
March 08, 2024 | 6.763 |
March 07, 2024 | 6.812 |
March 06, 2024 | 6.812 |
March 05, 2024 | 6.910 |
March 04, 2024 | 6.960 |
March 01, 2024 | 6.861 |
February 29, 2024 | 6.616 |
February 28, 2024 | 6.910 |
February 27, 2024 | 6.960 |
February 26, 2024 | 7.008 |
February 23, 2024 | 6.763 |
February 22, 2024 | 7.106 |
February 21, 2024 | 7.401 |
February 20, 2024 | 6.616 |
February 16, 2024 | 6.469 |
February 15, 2024 | 6.420 |
February 14, 2024 | 6.322 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
1.968
Minimum
Mar 18 2020
9.414
Maximum
Apr 09 2024
5.254
Average
5.181
Median
May 04 2021
Price to Book Value Benchmarks
AIM ImmunoTech Inc | 2.125 |
Perspective Therapeutics Inc | 12.49 |
Protalix BioTherapeutics Inc | 2.568 |
Electromed Inc | 3.451 |
Armata Pharmaceuticals Inc | -- |
Price to Book Value Related Metrics
PS Ratio | 14.80 |
Price | 1.49 |
Earnings Yield | -16.11% |
Market Cap | 43.17M |